Jeyran Shahbazi

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: “Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence”.

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

International Journal of Drug Policy(2021)10.1016/j.drugpo.2021.103492

N/A

2.1DataRank · unranked

52 citations

Jeyran Shahbazi, Marianne Byrne, Jason Grebely, Nicholas Lintzeris, Mark S. Chambers +13 more

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial

International Journal of Drug Policy(2024)10.1016/j.drugpo.2024.104390

N/A

0.730DataRank · unranked

21 citations

Jeyran Shahbazi, Mark S. Chambers, Marianne Byrne, Jaleh Gholami, Emma Zahra +14 more

Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence

International Journal of Drug Policy(2024)10.1016/j.drugpo.2024.104359

N/A

0.616DataRank · unranked

15 citations

Sandra Gendera, Carla Treloar, Tim Rhodes, Jeyran Shahbazi, Marianne Byrne +4 more

Supplementary Figure S4 from The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects

INDIGO (University of Illinois at Chicago)10.1158/1078-0432.22459383.v1

N/A

0DataRank · unranked

0 citations

Pei Y. Liu, Bernard Atmadibrata, James E. Bradner, Glenn M. Marshall, Richard B. Lock +2 more

Supplementary Table S1 from The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects

10.1158/1078-0432.22459374

N/A

0DataRank · unranked

0 citations

Pei Y. Liu, Bernard Atmadibrata, James E. Bradner, Glenn M. Marshall, Richard B. Lock +2 more

Supplementary Figure S2 from The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects

10.1158/1078-0432.22459389

N/A

0DataRank · unranked

0 citations

Pei Y. Liu, Bernard Atmadibrata, James E. Bradner, Glenn M. Marshall, Richard B. Lock +2 more